From Global Health to Capitol Hill: An Expert's Bid for Congress

NEW YORK, NY – April 03, 2026 – In one of the nation's most politically engaged and affluent congressional districts, a different kind of candidate is making her case. Nina Schwalbe, a global health expert with a three-decade career spanning over 100 countries, is running for the Democratic nomination in New York’s 12th District, arguing that what Congress needs most is a dose of scientific expertise.

Her campaign received a significant boost this week with a major profile in The Lancet, one of the world’s most prestigious medical journals. The feature highlights Schwalbe’s extensive career and frames her candidacy as an urgent response to a crisis of scientific integrity in American governance. “I’m running because we are in deep trouble, and we can do better,” Schwalbe stated in the press release announcing the profile. Her message is a direct challenge to what she describes as a political environment actively undermining the institutions designed to protect public health.

A Career on the Frontlines of Health Crises

Schwalbe's political ambitions are rooted in a lifetime spent on the frontlines of global health challenges. Her journey began after witnessing a devastating measles outbreak in a Thai refugee camp, an experience that solidified her commitment to public health. This path led to senior roles at some of the world's most influential health organizations, including UNICEF, the TB Alliance, and Gavi, the Vaccine Alliance.

At Gavi, former New Zealand Prime Minister Helen Clark praised Schwalbe’s “transformative leadership,” particularly her work in drastically cutting the cost of lifesaving medicines for the world's poorest populations. More recently, during the COVID-19 pandemic, she founded and directed the U.S. Agency for International Development's (USAID) COVID-19 Vaccine Access and Delivery Initiative, a $7 billion program. Colleagues describe her as a formidable force for equity. “She is a consistent and principled champion of equity, gender equality, and social justice,” said Pascale Allotey, the WHO’s Director of Sexual and Reproductive Health, who noted Schwalbe's combination of "intellectual precision with deep moral clarity."

This background as a "doer" and a non-politician is central to her pitch. She isn't just criticizing from the sidelines; she is positioning herself as someone who has built and run the very systems she now seeks to repair from within Congress. She holds a Master of Public Health from Columbia University and a PhD from the University of the Witwatersrand, and her family has roots in the district stretching back six generations, grounding her global experience with a deep local connection.

A Crowded Primary for a Coveted Seat

Schwalbe’s unique resume is being tested in one of the city's most competitive Democratic primaries. The retirement of longtime incumbent Representative Jerrold Nadler has turned the race for NY-12 into an open and crowded contest. The district, which stretches across parts of Manhattan's East and West Sides, is one of the most reliably Democratic in the country, with a Cook Partisan Voter Index of D+33. This means the winner of the June 23 primary is all but guaranteed a seat in Congress.

The field is packed with formidable opponents. Leading contenders include Assembly Members Micah Lasher, who has secured Nadler's endorsement and significant financial backing, and Alex Bores. The race also features candidates with national profiles, such as attorney and prominent Trump critic George Conway and Jack Schlossberg, the nephew of John F. Kennedy Jr. In this environment, Schwalbe is betting that her substantive, policy-driven platform can cut through the noise of established political machinery and celebrity power. She is framing the choice for voters as one between career politicians and a problem-solver with tangible, large-scale management experience.

A Campaign to Restore Science and Trust

The core of Schwalbe's campaign is a direct response to the erosion of trust and funding for America's key public health institutions. “This administration is fueling disinformation, propagating false science, stopping vaccine programs, denying climate change, slashing health and education programs,” Schwalbe said. “We urgently need to restore the CDC, the NIH, the FDA, and all the underlying infrastructure, talent, and expertise that keep us safe.”

Her warnings are not abstract. Recent years have seen these agencies face significant headwinds. The National Institutes of Health (NIH) has contended with budget cuts and grant disruptions that have stalled research and led to an exodus of scientific talent. The Centers for Disease Control and Prevention (CDC) has also faced funding delays and continues to battle a wave of public misinformation that complicates its mission. Schwalbe argues that Congress currently lacks the specific expertise to effectively counter these trends and conduct meaningful oversight.

Her proposed solution is not just about funding but also about embedding scientific literacy into the legislative process. On her campaign website, she outlines a detailed policy agenda that translates her global experience into domestic action. She is advocating for a single-payer healthcare system, to be achieved by incrementally lowering the Medicare eligibility age. On her first day, she plans to introduce an "American Health Security Act" aimed at lowering drug prices. Her platform also includes robust protections for LGBTQ+ workers, expanded mental health and addiction services, and a call to reform immigration by investing in a more humane system.

As the primary approaches, Schwalbe’s candidacy poses a fundamental question to the voters of NY-12: in an era defined by complex crises from pandemics to climate change, is it time to send an expert to Washington? Her campaign is a test of whether deep, specialized knowledge can be a winning political asset. With the primary less than three months away, voters in New York's 12th District will decide whether a career dedicated to global health is the right prescription for the challenges facing Congress.